Compare Maha Properti Indonesia Tbk. (MPRO) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maha Properti Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Maha Properti Indonesia Tbk. trades at Rp12,050 (market cap 119.31T, 3.9K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Maha Properti Indonesia Tbk. is far larger — about 1142.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MPRO | SCPI | |
|---|---|---|
Market Cap | 119.31T | 104.4B |
Volume | 3.9K | — |
Lot | 39 | — |
Turnover | 46.91M | — |
Average Price | 12,028.85 | — |
Value | 46.91M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Maha Properti Indonesia Tbk.
PT Propertindo Mulia Investama Tbk (formerly PT Agro Mulia Investama) (the Entity) was established based on Notarial Deed No. 2 of Notary Benediktus Andy Widyanto, S.H., dated March 5, 2004.
Read more on MPRO →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
